Fatal Vipera xanthina palestinae envenomation in 16 dogs

Veterinary and Human Toxicology

Volumn 46, Issue 5, 2004, Pages 268-272

  Aroch, I ^a   Segev, G ^a   Klement, E ^a   Shipov, A ^a   Harrus, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GLUCOCORTICOID; VENOM ANTISERUM;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE KIDNEY FAILURE; ANIMAL LAMENESS; ARTICLE; AUTOPSY; BIOCHEMISTRY; BLEEDING; CONTROLLED STUDY; DEPRESSION; DISSEMINATED INTRAVASCULAR CLOTTING; DOG; DYSPNEA; EDEMA; ENVENOMATION; ENZYME ACTIVITY; HEART ARRHYTHMIA; HYPOCHOLESTEROLEMIA; NONHUMAN; PAIN; SNAKE; SOFT TISSUE;

ANIMALS; DOG DISEASES; DOGS; DYSPNEA; EDEMA; FATAL OUTCOME; GLUCOCORTICOIDS; HEMATOLOGIC TESTS; HEMORRHAGE; PAIN; RETROSPECTIVE STUDIES; SNAKE BITES; VIPERIDAE;

ANIMALIA; CANIS FAMILIARIS; SERPENTES; VIPERA; VIPERA PALAESTINAE; VIPERA XANTHINA; XANTHINA;

EID: 4544371169     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mendelssohn H: On the biology of venomous snakes in Israel, Isr J Zool 12: 143-170, 1963.
2. Aroch I, Harrus S: Retrospective study of the epidemiological, clinical, haematological and biochemical findings in 109 dogs poisoned by Vipera xanthina palestinae. Vet Rec 144: 532-535, 1999.
3. Coppola M, Hogan DE. Venomous snakes of southwest Asia. Am J Emergen Med 10: 230-236, 1992.
4. Mann G: Snake Bites in Israel. PhD thesis, School of Medicine, The Hebrew University of Jerusalem, 1976.
5. Bicher HI, Gitter S, Rosen M: On the mechanism of Vipera palaestinae venom-induced shock. Bibliot Anatomica 7: 429-433, 1965.
6. Efrati P, Reif L: Clinical and pathological observations on sixty-five cases of viper bite in Israel. Am J Trop Med Hyg 2: 1085-1108, 1953.
7. Kangstrom LE: Snakebites (Vipera berus) in dogs and cats. Svensk Veterinartidning 41: 38-46, 1989.
8. Hackett TB, Wingfield WE, Mazzferro EM et al: Clinical findings associated with prairie rattlesnake bites in dogs: 100 cases (1989-1998). J Am Vet Assoc 220: 1675-1680, 2002.
9. Grotto L, Moroz C, De Vries A et al: Isolation of Vipera palestinae hemorrhagin and distinction between its hemorrhagic and proteolytic activities. Biochimica et biophysica acta. 21: 356-62, 1967.
10. Grotto L, Jerushalmy Z, De Vries A: Effect of purified Vipera palestinae haemorrhagin on blood coagulation and platelet function. Thromb Diath Haemorr 13: 482-495, 1969.
11. McKay DG, Moroz C, De Vries A et al: The action of hemorrhagin and phospholipase derived from Vipera palestinae venom on the microcirculation. Lab Invest 22: 387-99, 1970.
12. Shiloah J, Klibinsky C, De Vries A et al: Phospholipase B activity of a purified phospholipase A from Vipera palestinae venom. J Lip Res 14: 267-278, 1973.
13. Lloret S, Moreno LL: Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venom. Toxicon 31: 949-956, 1993.
14. Gutierrez JM, Rucavad A: Snake venom metalloproteinases: Their role in the pathogenesis of local tissue damage. Biochemie 82: 841-850, 2000.
15. Kochva, S Perlmutter CH, Gitter S et al: Studies on Vipera palestinae venom. Fractionation by ion exchange chromatography. Am J Trop Med Hyg 9: 374-380, 1960.
16. Rechnic J, De Vries A, Perlmutter CH et al: Coagulation factors in the venom of Vipera palestinae and Echis colorata. Bulletin of the research council of Israel. Section E. Experimental medicine. 8: 81-86, 1960.
17. Samel M, Siiger L: Medium molecular weight factor X activating enzyme from Vipera berus berus venom. Toxicon 33: 41-52, 1995.
18. Yamada D, Sekiya F, Morita T: Prothrombin and factor X activator activities in the venoms of Vipendae snakes. Toxicon 35: 1581-1589, 1997.
19. Tans G, Rosing J: Snake venom activators of factor X: an overview. Haemostasis 31: 225-233, 2001.
20. Bicher HI, Roth M, Gitter S: Neurotoxic activity of Vipera palestinae venom. Depression of central autonomic vasoregulatory mechanisms. Int J Exp Med 14: 349-59, 1966.
21. Moroz C, De Vries A, Sela M: Isolation and characterization of a neurotoxin from Vipera palestinae venom. Biochimica et biophysica Acta 27: 136-46, 1966.
22. Moroz C, De Vries A, Goldblum N: Preparation of an antivenin against Vipera palestinae venom with high antineurotoxic potency. Toxicon. 4: 205-208, 1966.
23. Gitter S, De Vries A, Kochva S: Recent studies on the venom of Vipera xanthina palestinae. Isr Med J 18: 10-21, 1959.
24. Winkler E, Chovers M, Almog S et al: Decreased serum cholesterol level after snakebite (Vipera palestinae) as a marker of severity of envenomation. J Lab Clin Med 121: 774-778, 1993.
25. th Forum Am College Vet Intl Med, Seattle, WA: pp 48-49, 2000.
26. Moroz C, Hahn J, De Vries A: Neutralization of Vipera palestinae hemorrhagin by antibody fragments. Toxicon. 9: 57-62, 1971.
27. Allon N, Kochva E: The quantities of venom injected to pray of different size by Vipera palestinae in a single bite. J Exp Zool 188: 71-76, 1974.
28. Efrati P: Clinical manifestation and treatment of viper bite in Israel: Toxicon 7: 29-31, 1969.
29. Efrati P, Reif L: Viper bites. Family Physician (in Hebrew) 7: 94-104, 1977.
30. Hoffman A, Levi O, Orgad U et al: Myocarditis following envenomation with Vipera palestinae in two horses. Toxicon 31: 1623-28, 1993.